( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author Wikidata ID:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):

Erminia Massarelli

Wikidata Item | Scholia Profile [curation] | Reasonator | SQID

Listed Publications

42 publications found

TitleAuthors (identified)Published InIdentifier(s)TopicPublished Date
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy[1]Arin Nam, [2]Atish Mohanty, [3]Supriyo Bhattacharya, [4]Sourabh Kotnala, [5]Srisairam Achuthan, [6]Kishore Hari, [7]Saumya Srivastava, [8]Linlin Guo, [9]Anusha Nathan, [10]Rishov Chatterjee, [11]Maneesh Jain, [12]Mohd W Nasser, [13]Surinder K Batra, [14]Govindan Rangarajan, [15]Erminia Massarelli, [16]Herbert Levine, [17]Mohit Kumar Jolly, [18]Prakash Kulkarni, [19]Ravi Salgia [Full author list]Biomolecules [curation]DOI: 10.3390/BIOM12010008
PubMed: 35053156
2021-12-21
Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure[1]Ranjan Pathak, [2]Rebecca R Pharaon, [3]Atish Mohanty, [4]Victoria M Villaflor, [5]Ravi Salgia, [6]Erminia Massarelli [Full author list]Cancers [curation]DOI: 10.3390/CANCERS12123851
PubMed: 33419311
2020-12-20
An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites[1]Rebecca Pharaon, [2]Samuel Chung, [3]Arya Amini, [4]Ellie Maghami, [5]Arnab Chowdhury, [6]Nayana Vora, [7]Sue Chang, [8]Robert Kang, [9]Thomas Gernon, [10]Kelly Hansen, [11]Christina Kelly, [12]Denise Ackerman, [13]Lalit Vora, [14]Sagus Sampath, [15]Erminia Massarelli [Full author list]Journal of Clinical Medicine [curation]DOI: 10.3390/JCM9103083
PubMed: 32987866
oropharyngeal squamous cell carcinoma [curation]2020-09-24
Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?[1]Victoria M Villaflor, [2]Erminia Massarelli [Full author list]Journal of Oncology Practice [curation]DOI: 10.1200/OP.20.00656
PubMed: 32946323
2020-09-18
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials[1]Atish Mohanty, [2]Rebecca R Pharaon, [3]Arin Nam, [4]Sabrina Salgia, [5]Prakash Kulkarni, [6]Erminia Massarelli [Full author list]Expert Opinion on Investigational Drugs [curation]DOI: 10.1080/13543784.2020.1740680
PubMed: 32178538
phase I clinical trial [curation]2020-03-19
Precision medicine and actionable alterations in lung cancer: A single institution experience[1]Isa Mambetsariev, [2]Yingyu Wang, [3]Chen Chen, [4]Sorena Nadaf, [5]Rebecca Pharaon, [6]Jeremy Fricke, [7]Idoroenyi Amanam, [8]Arya Amini, [9]Andrea Bild, [10]Peiguo Chu, ..., [19]Lynette Smith, [20]Surinder K Batra, [21]Erminia Massarelli, [22]Marianna Koczywas, [23]Karen Reckamp, ... [Full author list]PLOS One [curation]DOI: 10.1371/JOURNAL.PONE.0228188
PubMed: 32045431
2020-02-11
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer[1]Erminia Massarelli, [2]Vincent K Lam, [3]Edwin R Parra, [4]Jaime Rodriguez-Canales, [5]Carmen Behrens, [6]Lixia Diao, [7]Jing Wang, [8]Jorge Blando, [9]Lauren A Byers, [10]Niranjan Yanamandra, [11]Sara Brett, [12]Peter Morley, [13]Padmanee Sharma, [14]James Allison, [15]Ignacio I Wistuba, [16]John V Heymach [Full author list]Journal for Immunotherapy of Cancer [curation]DOI: 10.1186/S40425-019-0827-2
PubMed: 31843013
2019-12-16
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses[1]James W Welsh, [2]Chad Tang, [3]Patricia de Groot, [4]Aung Naing, [5]Kenneth R Hess, [6]John V Heymach, [7]Vassiliki Papadimitrakopoulou, [8]Taylor R Cushman, [9]Vivek Subbiah, [10]Joe Y Chang, ..., [14]Hari Menon, [15]Maria Angelica Cortez, [16]Erminia Massarelli, [17]Quynh Nguyen, [18]Padmanee Sharma, ... [Full author list]Cancer Immunology Research [curation]DOI: 10.1158/2326-6066.CIR-18-0793
PubMed: 31658994
phase II clinical trial [curation]2019-10-28
Factors predicting for patient refusal of head and neck cancer therapy[1]Arya Amini, [2]Vivek Verma, [3]Richard Li, [4]Nayana Vora, [5]Robert Kang, [6]Thomas J Gernon, [7]Sue Chang, [8]Sana Karam, [9]Erminia Massarelli, [10]Ellie G Maghami, [11]Scott Glaser [Full author list]Head & Neck [curation]DOI: 10.1002/HED.25966
PubMed: 31584746
head and neck cancer [curation]; head and neck carcinoma [curation]; neck cancer [curation]2019-10-04
Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio[1]Ashwin Shinde, [2]Zachary D Horne, [3]Richard Li, [4]Scott Glaser, [5]Erminia Massarelli, [6]Marianna Koczywas, [7]Loretta Erhunmwunsee, [8]Karen L Reckamp, [9]Benny Weksler, [10]Ravi Salgia, [11]Sushil Beriwal, [12]Arya Amini [Full author list]Lung Cancer [curation]DOI: 10.1016/J.LUNGCAN.2019.05.020
PubMed: 31200820
non-small-cell lung carcinoma [curation]2019-05-19
Early mortality of stage IV non-small cell lung cancer in the United States[1]Arya Amini, [2]Vivek Verma, [3]Scott M Glaser, [4]Ashwin Shinde, [5]Sagus Sampath, [6]William A Stokes, [7]Chad G Rusthoven, [8]Erminia Massarelli, [9]Ravi Salgia, [10]Laurie E. Gaspar, [11]Arthur K Liu [Full author list]Acta Oncologica [curation]DOI: 10.1080/0284186X.2019.1599138
PubMed: 30958075
2019-04-08
Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma[1]Arya Amini, [2]William A Stokes, [3]Bernard L Jones, [4]Sagus Sampath, [5]Robert S Kang, [6]Thomas J Gernon, [7]Ellie G Maghami, [8]Erminia Massarelli, [9]Cathy J Bradley, [10]Sana D Karam [Full author list]Head & Neck [curation]DOI: 10.1002/HED.25697
PubMed: 30737961
oral squamous cell carcinoma [curation]2019-02-09
Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort[1]Neil H Segal, [2]Sai-Hong I Ou, [3]Ani Balmanoukian, [4]Matthew G Fury, [5]Erminia Massarelli, [6]Julie R Brahmer, [7]Jared Weiss, [8]Patrick Schöffski, [9]Scott J Antonia, [10]Christophe Massard, [11]Dan P Zandberg, [12]Samir N Khleif, [13]Feng Xiao, [14]Marlon C Rebelatto, [15]Keith E Steele, [16]Paul B Robbins, [17]Natasha Angra, [18]Xuyang Song, [19]Shaad Abdullah, [20]Marcus Butler [Full author list]European Journal of Cancer [curation]DOI: 10.1016/J.EJCA.2018.12.029
PubMed: 30731276
head and neck squamous cell carcinoma [curation]2019-02-04
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial[1]Erminia Massarelli, [2]William William, [3]Faye Johnson, [4]Merrill Kies, [5]Renata Ferrarotto, [6]Ming Guo, [7]Lei Feng, [8]J Jack Lee, [9]Hai Tran, [10]Young Uk Kim, ... [Full author list]JAMA Oncology [curation]DOI: 10.1001/JAMAONCOL.2018.4051
PubMed: 30267032
phase II clinical trial [curation]; human papillomavirus 16 [curation]2019-01-01
Comparing outcomes of concurrent chemotherapy regimens in patients 65 years old or older with locally advanced oropharyngeal carcinoma[1]Arya Amini, [2]Megan Eguchi, [3]Bernard L Jones, [4]William A Stokes, [5]Abhinav Gupta, [6]Jessica D McDermott, [7]Erminia Massarelli, [8]Cathy J Bradley, [9]Sana D Karam [Full author list]Cancer [curation]DOI: 10.1002/CNCR.31740
PubMed: 30291789
chemotherapy [curation]2018-10-06
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.[1]Jun Gong, [2]Thang Q Le, [3]Erminia Massarelli, [4]Andrew E Hendifar, [5]Richard Tuli [Full author list]Journal for Immunotherapy of Cancer [curation]DOI: 10.1186/S40425-018-0361-7
PubMed: 29866197
radiation therapy [curation]; membrane protein [curation]; neoplasm [curation]2018-06-04
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.[1]Sagus Sampath, [2]Haejung Won, [3]Erminia Massarelli, [4]Min Li, [5]Paul Frankel, [6]Nayana Vora, [7]Lalit Vora, [8]Ellie Maghami, [9]Marcin Kortylewski [Full author list]Oncotarget [curation]DOI: 10.18632/ONCOTARGET.24397
PubMed: 29541413
head and neck cancer [curation]; head and neck carcinoma [curation]; neck cancer [curation]2018-02-02
Perspectives in Head and Neck Medical Oncology.[1]Idoroenyi Amanam, [2]Rohan Gupta, [3]Alain Mita, [4]Kevin Scher, [5]Erminia Massarelli [Full author list]Cancer Treatment and Research [curation]DOI: 10.1007/978-3-319-65421-8_10
PubMed: 29435842
2018-01-01
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study[1]Joshua Bauml, [2]Tanguy Y Seiwert, [3]David G Pfister, [4]Francis Worden, [5]Stephen V Liu, [6]Jill Gilbert, [7]Nabil F Saba, [8]Jared Weiss, [9]Lori Wirth, [10]Ammar Sukari, [11]Hyunseok Kang, [12]Michael K Gibson, [13]Erminia Massarelli, [14]Steven Powell, [15]Amy Meister, [16]Xinxin Shu, [17]Jonathan D Cheng, [18]Robert Haddad [Full author list]Journal of Clinical Oncology [curation]DOI: 10.1200/JCO.2016.70.1524
PubMed: 28328302
platinum [curation]; cetuximab [curation]; head and neck cancer [curation]; pembrolizumab [curation]; head and neck carcinoma [curation]; neck cancer [curation]2017-03-22
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one[1]Andreas Lundqvist, [2]Vincent van Hoef, [3]Xiaonan Zhang, [4]Erik Wennerberg, [5]Julie Lorent, [6]Kristina Witt, [7]Laia Masvidal Sanz, [8]Shuo Liang, [9]Shannon Murray, [10]Ola Larsson, ..., [65]Chantale Bernatchez, [66]Adi Diab, [67]Erminia Massarelli, [68]Neil H. Segal, [69]Vincent Ribrag, ... [Full author list]Journal for Immunotherapy of Cancer [curation]DOI: 10.1186/S40425-016-0172-7
immunotherapy [curation]2016-11-01
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells[1]Chad Tang, [2]James W Welsh, [3]Patricia de Groot, [4]Erminia Massarelli, [5]Joe Y Chang, [6]Kenneth R Hess, [7]Sreyashi Basu, [8]Michael A. Curran, [9]Maria E Cabanillas, [10]Vivek Subbiah, [11]Siqing Fu, [12]Apostolia Maria Tsimberidou, [13]Daniel Karp, [14]Daniel R Gomez, [15]Adi Diab, [16]Ritsuko Komaki, [17]John V Heymach, [18]Padmanee Sharma, [19]Aung Naing, [20]David S Hong [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-16-1432
PubMed: 27649551
radiation therapy [curation]; ipilimumab [curation]2016-09-20
Checkpoint inhibitors in lung cancer: latest developments and clinical potential[1]Gustavo Schvartsman, [2]Renata Ferrarotto, [3]Erminia Massarelli [Full author list]Therapeutic advances in medical oncology [curation]DOI: 10.1177/1758834016661164
PubMed: 27800034
lung cancer [curation]2016-07-26
Immune Checkpoint Therapy in Head and Neck Cancers[1]Pavlos Msaouel, [2]Erminia Massarelli [Full author list]The Cancer Journal [curation]DOI: 10.1097/PPO.0000000000000180
PubMed: 27111906
2016-03-01
New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic[1]Erminia Massarelli, [2]Renata Ferrarotto, [3]Bonnie S Glisson [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-14-1329
PubMed: 26330505
oropharynx cancer [curation]2015-09-01
Human Lung Fibroblasts Inhibit Non-Small Cell Lung Cancer Metastasis in Ex Vivo 4D Model[1]Dhruva K Mishra, [2]Steven D Compean, [3]Michael J Thrall, [4]Xin Liu, [5]Erminia Massarelli, [6]Jonathan M Kurie, [7]Min P Kim [Full author list]The Annals of Thoracic Surgery [curation]DOI: 10.1016/J.ATHORACSUR.2015.05.014
PubMed: 26233278
cancer metastasis [curation]2015-07-30
Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion[1]Erminia Massarelli, [2]Dr. Bianca Lins, LL.M., [3]Edith M Marom, [4]Christine M Alden, [5]Diane D Liu, [6]Hai T Tran, [7]Barbara Mino, [8]Ignacio I Wistuba, [9]Saadia A Faiz, [10]Lara Bashoura, [11]George A Eapen, [12]Rodolfo C Morice, [13]J Jack Lee, [14]Waun K Hong, [15]Roy S. Herbst, [16]Carlos A Jimenez [Full author list]Clinical Lung Cancer [curation]DOI: 10.1016/J.CLLC.2014.04.002
PubMed: 24913066
catheterization [curation]; malignant pleural effusion [curation]2014-05-14
Immunotherapy in lung cancer.[1]Erminia Massarelli, [2]Vassiliki Papadimitrakopoulou, [3]James Welsh, [4]Chad Tang, [5]Anne S Tsao [Full author list]Translational lung cancer research [curation]DOI: 10.3978/J.ISSN.2218-6751.2014.01.01
PubMed: 25806281
immunotherapy [curation]2014-02-01
Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance[1]Erminia Massarelli, [2]Faye M Johnson, [3]Heidi S Erickson, [4]Ignacio I Wistuba, [5]Vassiliki Papadimitrakopoulou [Full author list]Lung Cancer [curation]DOI: 10.1016/J.LUNGCAN.2013.01.018
PubMed: 23485129
non-small-cell lung carcinoma [curation]2013-02-26
Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer[1]Erminia Massarelli, [2]Vassiliki Papadimitrakopoulou [Full author list]Journal of Thoracic Oncology [curation]DOI: 10.1097/JTO.0B013E31826DF0F0
PubMed: 23160325
sirolimus [curation]2012-12-01
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma[1]Pierre Saintigny, [2]Erminia Massarelli, [3]Steven Lin, [4]Young-Ho Ahn, [5]Yulong Chen, [6]Sangeeta Goswami, [7]Baruch Erez, [8]Michael S O'Reilly, [9]Diane Liu, [10]J Jack Lee, ... [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-12-0263
PubMed: 23204236
adenocarcinoma [curation]2012-11-30
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial[1]Merrill S Kies, [2]Floyd Christopher Holsinger, [3]J Jack Lee, [4]William N William, [5]Bonnie S Glisson, [6]Heather Y Lin, [7]Jan S Lewin, [8]Lawrence Ginsberg, [9]Katharine A Gillaspy, [10]Erminia Massarelli, [11]Lauren Byers, [12]Scott Lippman, [13]Waun K Hong, [14]Adel K El-Naggar, [15]Adam S Garden, [16]Vassiliki Papadimitrakopoulou [Full author list]Journal of Clinical Oncology [curation]DOI: 10.1200/JCO.2009.23.0425
PubMed: 19917840
cetuximab [curation]; chemotherapy [curation]; head and neck squamous cell carcinoma [curation]; phase II clinical trial [curation]2009-11-16
Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas[1]Ximing Tang, [2]Marileila Varella-Garcia, [3]Ana C Xavier, [4]Erminia Massarelli, [5]Natalie Ozburn, [6]Cesar Moran, [7]Ignacio I Wistuba [Full author list]Cancer Prevention Research [curation]DOI: 10.1158/1940-6207.CAPR-08-0032
PubMed: 19138956
adenocarcinoma [curation]; pathogenesis [curation]2008-08-01
KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer[1]Erminia Massarelli, [2]Marileila Varella-Garcia, [3]Ximing Tang, [4]Ana C Xavier, [5]Natalie C Ozburn, [6]Diane D Liu, [7]Benjamin N Bekele, [8]Roy S. Herbst, [9]Ignacio I Wistuba [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-06-3043
PubMed: 17504988
lung cancer [curation]2007-05-01
Use of novel second-line targeted therapies in non-small cell lung cancer[1]Erminia Massarelli, [2]Roy S. Herbst [Full author list]Seminars in Oncology [curation]DOI: 10.1053/J.SEMINONCOL.2005.12.007
PubMed: 16472704
2006-02-01
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor[1]Nobukazu Fujimoto, [2]Marie Wislez, [3]Jie Zhang, [4]Kentaro Iwanaga, [5]Jennifer Dackor, [6]Amy E Hanna, [7]Shailaja Kalyankrishna, [8]Dianna D Cody, [9]Roger E Price, [10]Mitsuo Sato, [11]Jerry W Shay, [12]John D Minna, [13]Michael Peyton, [14]Ximing Tang, [15]Erminia Massarelli, [16]Roy S. Herbst, [17]David W. Threadgill, [18]Ignacio I Wistuba, [19]Jonathan M Kurie [Full author list]Cancer Research [curation]DOI: 10.1158/0008-5472.CAN-05-1977
PubMed: 16357156
adenocarcinoma [curation]2005-12-01
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer[1]Michele De Laurentiis, [2]Grazia Arpino, [3]Erminia Massarelli, [4]Angela Ruggiero, [5]Chiara Carlomagno, [6]Fortunato Ciardiello, [7]Giampaolo Tortora, [8]Diego D'Agostino, [9]Francesca Caputo, [10]Giuseppe Cancello, [11]Emilia Montagna, [12]Luca Malorni, [13]Luigia Zinno, [14]Rossella Lauria, [15]Angelo Raffaele Bianco, [16]Sabino De Placido, [8-Q57081048]Michelino De Laurentiis [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-04-2569
PubMed: 16000569
meta-analysis [curation]2005-07-01
Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis[1]Erminia Massarelli, [2]Erika Brown, [3]Ngoc K Tran, [4]Diane D Liu, [5]Julie G Izzo, [6]J Jack Lee, [7]Adel K El-Naggar, [8]Waun K Hong, [9]Vassiliki Papadimitrakopoulou [Full author list]Cancer [curation]DOI: 10.1002/CNCR.20879
PubMed: 15666322
2005-03-01
Akt activation correlates with adverse outcome in tongue cancer[1]Erminia Massarelli, [2]Diane D. Liu, [3]J. Jack Lee, [4]Adel K. El-Naggar, [5]Lorenzo Lo Muzio, [6]Stefania Staibano, [7]Sabino De Placido, [8]Jeffrey N. Myers, [9]Vassiliki Papadimitrakopoulou [Full author list]Cancer [curation]DOI: 10.1002/CNCR.21476
PubMed: 16245318
cancer research [curation]; tongue cancer [curation]2005-01-01
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly[1]Cesare Gridelli, [2]Erminia Massarelli, [3]Paolo Maione, [4]Antonio Rossi, [5]Roy S. Herbst, [6]Dr. Bianca Lins, LL.M., [7]Fortunato Ciardiello [Full author list]Cancer [curation]DOI: 10.1002/CNCR.20572
PubMed: 15386339
lung carcinoma [curation]2004-10-01
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres[1]Ralph G Zinner, [2]Bonnie S Glisson, [3]Frank V Fossella, [4]Katherine M W Pisters, [5]Merril S Kies, [6]Pamela M Lee, [7]Erminia Massarelli, [8]Bradley Sabloff, [9]Herbert A Fritsche, [10]Jae Y Ro, [11]Nelson G Ordonez, [12]Hai T Tran, [13]Ying Yang, [14]Terry L Smith, [15]Robert D Mass, [16]Roy S. Herbst [Full author list]Lung Cancer [curation]DOI: 10.1016/J.LUNGCAN.2003.09.026
PubMed: 15013588
patient [curation]; cisplatin [curation]; trastuzumab [curation]; phase II clinical trial [curation]; overexpression [curation]2004-04-01
Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer[1]Dr. Bianca Lins, LL.M., [2]Arlene M Correa, [3]Michael Gilcrease, [4]Takeshi Isobe, [5]Erminia Massarelli, [6]Corazon D Bucana, [7]Michael S O'Reilly, [8]Waun K Hong, [9]Isaiah J Fidler, [10]Joe B Putnam, [11]Roy S. Herbst [Full author list]Clinical Cancer Research [curation]DOI: 10.1158/1078-0432.CCR-0373-3
PubMed: 14734462
overexpression [curation]2004-01-01
New targets for the treatment of advanced non-small cell lung cancer[1]Erminia Massarelli, [2]Amir Onn, [2-Q89538379]Dr. Bianca Lins, LL.M., [3]Ralph Zinner, [4]Fadlo R. Khuri, [5]Edward S. Kim, [6]Roy S. Herbst [Full author list]Cancer chemotherapy and biological response modifiers [curation]PubMed: 127032322002-01-01
Correct Q number of author item for selected works.
NO replacement author: revert to author name strings

Common author items in these papers

Common names in these papers


Feedback
Source and documentation (at github)
Wikidata page